SE9201208L - Förfarande för framställning av stabila beta-blockerar-innehållande läkemedel i flytande form med reglerad frisättning av den aktiva beståndsdelen för oral administrering - Google Patents

Förfarande för framställning av stabila beta-blockerar-innehållande läkemedel i flytande form med reglerad frisättning av den aktiva beståndsdelen för oral administrering

Info

Publication number
SE9201208L
SE9201208L SE9201208A SE9201208A SE9201208L SE 9201208 L SE9201208 L SE 9201208L SE 9201208 A SE9201208 A SE 9201208A SE 9201208 A SE9201208 A SE 9201208A SE 9201208 L SE9201208 L SE 9201208L
Authority
SE
Sweden
Prior art keywords
beta
oral administration
controlled release
parts
blocker
Prior art date
Application number
SE9201208A
Other languages
English (en)
Other versions
SE9201208D0 (sv
Inventor
I Racz
S Marton
Original Assignee
Synepos Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synepos Ag filed Critical Synepos Ag
Publication of SE9201208D0 publication Critical patent/SE9201208D0/sv
Publication of SE9201208L publication Critical patent/SE9201208L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE9201208A 1992-03-13 1992-04-15 Förfarande för framställning av stabila beta-blockerar-innehållande läkemedel i flytande form med reglerad frisättning av den aktiva beståndsdelen för oral administrering SE9201208L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9200866A HU209251B (en) 1992-03-13 1992-03-13 Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US08/135,992 US5484776A (en) 1992-03-13 1993-10-14 Process for the production of stable liquid form of beta-blocker-containing medicaments with controlled release of the active constituent for oral administration

Publications (2)

Publication Number Publication Date
SE9201208D0 SE9201208D0 (sv) 1992-04-15
SE9201208L true SE9201208L (sv) 1993-09-14

Family

ID=26318071

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201208A SE9201208L (sv) 1992-03-13 1992-04-15 Förfarande för framställning av stabila beta-blockerar-innehållande läkemedel i flytande form med reglerad frisättning av den aktiva beståndsdelen för oral administrering

Country Status (7)

Country Link
US (1) US5484776A (sv)
DE (1) DE4212640A1 (sv)
FR (1) FR2688405B1 (sv)
GB (1) GB2264866A (sv)
HU (1) HU209251B (sv)
IT (1) IT1254953B (sv)
SE (1) SE9201208L (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4331539A1 (de) * 1993-09-17 1995-03-23 Basf Ag Dextranester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Umhüllung oder Einbettung von Arzneimitteln
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399359A (en) * 1994-03-04 1995-03-21 Edward Mendell Co., Inc. Controlled release oxybutynin formulations
ES2246961T3 (es) * 1994-04-25 2006-03-01 Penwest Pharmaceuticals Co. Excipiente de liberacion sostenida.
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form
AU2068797A (en) * 1996-01-29 1997-08-20 Edward Mendell Co. Inc. Sustained release excipient
JPH10139670A (ja) * 1996-11-11 1998-05-26 Terukuni Yakida インターロイキン１２誘導物質及び医薬組成物
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
EP1113785B1 (en) 1998-07-24 2005-04-13 Seo Hong Yoo Clear aqueous solutions of bile acids
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
CA2406930C (en) * 2000-02-04 2011-02-15 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
MXPA04009701A (es) * 2002-04-05 2005-05-27 Penwest Pharmaceuticals Co Formulaciones de metoprolol de liberacion sostenida.
US7145125B2 (en) * 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
JP2008511651A (ja) * 2004-08-30 2008-04-17 セオ ホン ユー 局所虚血モデルでの可溶化ｕｄｃａの神経保護効果
KR20070084211A (ko) * 2004-10-15 2007-08-24 유서홍 약제학적 화합물의 독성을 감소시키기 위한 방법 및 조성물
KR101358078B1 (ko) * 2004-11-01 2014-02-06 주식회사 유스팜인터내셔널 근위축성 측삭 경화증의 신경퇴행을 감소시키기 위한 방법및 조성물
DE102006020604A1 (de) * 2006-05-02 2007-11-08 Bayer Healthcare Ag Flüssige Arzneimittelformulierung
EP2246044A1 (en) * 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
US9724297B2 (en) * 2014-04-01 2017-08-08 Arbor Pharmaceuticals, Inc. Sotalol compositions and uses of the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR148F (sv) * 1962-01-24
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
SE441525B (sv) * 1978-05-19 1985-10-14 Ici Ltd P-hydroxifenylettiksyra
US4394390A (en) * 1979-08-03 1983-07-19 University Of Kentucky Research Foundation Nasal dosage forms of propranol
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
JPS59130866A (ja) * 1983-01-17 1984-07-27 Zeria Shinyaku Kogyo Kk ピンドロ−ル製剤の製造法
US4689235A (en) * 1984-01-31 1987-08-25 Scm Corporation Encapsulation matrix composition and encapsulate containing same
GB8402573D0 (en) * 1984-02-01 1984-03-07 Fisons Plc Oral formulation
US4579867A (en) * 1984-04-09 1986-04-01 American Hospital Supply Corporation Stable pharmaceutical compositions of short-acting β-adrenergic receptor blocking agents
US4885293A (en) * 1984-09-24 1989-12-05 Schering Corporation Antiglaucoma agents
US4600708A (en) * 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
GB8522453D0 (en) * 1985-09-11 1985-10-16 Lilly Industries Ltd Chewable capsules
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US4915949A (en) * 1987-07-13 1990-04-10 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
IT1234194B (it) * 1988-05-31 1992-05-06 Magis Farmaceutici Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione
DE4004656C1 (sv) * 1990-02-15 1991-05-02 Melitta Haushaltsprodukte Gmbh & Co Kg, 4950 Minden, De
US5100688A (en) * 1990-02-23 1992-03-31 Cox James P Saccharide/protein gel
US5225219A (en) * 1992-01-02 1993-07-06 The United States Of America, As Represented By The Secretary Of Agriculture Amylodextrin compositions and method therefor

Also Published As

Publication number Publication date
ITMI921022A1 (it) 1993-10-30
US5484776A (en) 1996-01-16
HUT63580A (en) 1993-09-28
DE4212640A1 (de) 1993-09-16
IT1254953B (it) 1995-10-11
GB2264866A (en) 1993-09-15
FR2688405A1 (fr) 1993-09-17
FR2688405B1 (fr) 1995-03-03
HU209251B (en) 1994-04-28
ITMI921022A0 (it) 1992-04-30
HU9200866D0 (en) 1992-05-28
GB9208518D0 (en) 1992-06-03
SE9201208D0 (sv) 1992-04-15

Similar Documents

Publication Publication Date Title
SE9201208L (sv) Förfarande för framställning av stabila beta-blockerar-innehållande läkemedel i flytande form med reglerad frisättning av den aktiva beståndsdelen för oral administrering
BR9008022A (pt) Amida de acido isoxazol-4-carboxilico e amidas de acido hidroxialquilideno-cianoacetico,medicamentos contendo estes compostos e sua aplicacao
EP0019403B1 (en) Hydroxyalkyl-starch drug carrier
US4952684A (en) Processes for the preparation of amides and amines from a material having carboxyl-containing polysaccharides and products therefrom
JPS5929190B2 (ja) スルホンアミド化合物
FR2359823A1 (fr) 2-benzyl-pyrrolidines, procede pour leur preparation et medicament contenant ces composes
US4963664A (en) Processes for the preparation of amides and amines from a material having carboxyl-containing polysaccharides and products therefrom
EP0249779B1 (en) Methylated chitosans and their use for the preparation of pharmaceutical compositions
US3851057A (en) Dextran derivatives for the reduction of blood lipids
SU1469826A1 (ru) Сополимер l-лизина с l-глутаминовой кислотой, содержащий дофаминовые боковые группы, обладающий пролонгированной гипотензивной активностью и компенсаторным эффектом при геморрагическом шоке, и способ его получения
US4001231A (en) Process for making a methenamine salt of an optically active acid
KR950032255A (ko) 말토실 글루코시드 결정 및 그 제조방법과 용도
US4959461A (en) Processes for the preparation of amides and amines from a material having carboxyl-containing polysaccharides and products therefrom
SU1028680A1 (ru) Способ получени простого эфира полисахарида
KR20000045851A (ko) 키토산 유도체의 제조방법
JPH02105801A (ja) 新規なキトサン化合物、該化合物の製造方法および保湿剤としての用途
JP2687141B2 (ja) 新規なキトサン化合物、該化合物の製造方法および該化合物を含む保湿剤
SE469209B (sv) Terapeutisk komposition innehaallande hydrolyserad karboxialkylcellulosa
GB1578977A (en) Salts of aliphatic-thioethylamines
RU2118161C1 (ru) Противовоспалительное средство
SU591187A1 (ru) М-холиномиметическое средство "целукарпин
Poth et al. Studies on Rates of Hydrolysis of N Dibasic Acid Substituted Sulfonamides.∗
CN117903226A (zh) 一种氟尿嘧啶及其制药用途、药物/前药和制备方法
GB1014046A (en) Therapeutic compound
GB1391305A (en) Phenylalkylamines

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9201208-7

Format of ref document f/p: F